A detailed history of Fieldpoint Private Securities, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 669 shares of GH stock, worth $23,769. This represents 0.01% of its overall portfolio holdings.

Number of Shares
669
Previous 670 0.15%
Holding current value
$23,769
Previous $44,000 38.64%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$28.82 - $77.35 $28 - $77
-1 Reduced 0.15%
669 $27,000
Q2 2021

Aug 12, 2021

SELL
$109.77 - $165.68 $1,097 - $1,656
-10 Reduced 1.47%
670 $70,000
Q1 2021

Apr 23, 2021

SELL
$127.04 - $179.1 $25,280 - $35,640
-199 Reduced 22.64%
680 $104,000
Q4 2020

Jan 28, 2021

BUY
$99.96 - $135.93 $87,864 - $119,482
879 New
879 $113,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.63B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Fieldpoint Private Securities, LLC Portfolio

Follow Fieldpoint Private Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.